DCPSA FFPM - Bionomics Consultant Neuroscience
| BNOXDelisted Stock | USD 4.88 0.07 1.41% |
Insider
DCPSA FFPM is Consultant Neuroscience of Bionomics Ltd ADR
| Phone | 61 8 8150 7400 |
| Web | https://www.bionomics.com.au |
Bionomics Management Efficiency
The company has return on total asset (ROA) of (0.3958) % which means that it has lost $0.3958 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7844) %, meaning that it created substantial loss on money invested by shareholders. Bionomics' management efficiency ratios could be used to measure how well Bionomics manages its routine affairs as well as how well it operates its assets and liabilities.Bionomics Ltd ADR currently holds 272.74 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Bionomics ADR has a current ratio of 12.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Bionomics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Jeff Fensterer | Accustem Sciences | 44 | |
| Hunter MD | Aerovate Therapeutics | 59 | |
| Deepika PharmD | Pmv Pharmaceuticals | 49 | |
| Timothy MBA | Aerovate Therapeutics | 63 | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Man MBA | Adagene | 48 | |
| Guizhong Liu | Adagene | 54 | |
| Fangyong Du | Adagene | 54 | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| Wendy Blosser | Accustem Sciences | 57 | |
| Oz CPA | Scisparc | 38 | |
| Josh Eizen | AN2 Therapeutics | N/A | |
| Eric Devroe | Acrivon Therapeutics, Common | 46 | |
| Qinghai Zhao | Adagene | 64 | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| Arnold Levine | Pmv Pharmaceuticals | 85 | |
| Peter MD | Acrivon Therapeutics, Common | 62 | |
| MBA MR | Aerovate Therapeutics | 62 | |
| David Mack | Pmv Pharmaceuticals | 63 | |
| Winston MBA | Pmv Pharmaceuticals | 48 | |
| Crystal Mercado | Acrivon Therapeutics, Common | N/A | |
Management Performance
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 |
Bionomics ADR Leadership Team
Elected by the shareholders, the Bionomics' board of directors comprises two types of representatives: Bionomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bionomics. The board's role is to monitor Bionomics' management team and ensure that shareholders' interests are well served. Bionomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bionomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Spyridon MD, President CEO | ||
| Elizabeth Doolin, Senior Development | ||
| DCPSA FFPM, Consultant Neuroscience | ||
| Errol Souza, Ex Chairman | ||
| FCA BEC, Financial Controller | ||
| FCIS BCom, Company Secretary | ||
| MD DFAPA, Acting Officer | ||
| Julie Kerner, Senior Operations | ||
| Connor MSc, VP Devel |
Bionomics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bionomics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.78 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | 89.10 % | |||
| Current Valuation | 14.16 B | |||
| Shares Outstanding | 1.63 M | |||
| Shares Owned By Insiders | 33.91 % | |||
| Shares Owned By Institutions | 16.22 % | |||
| Number Of Shares Shorted | 400.4 K | |||
| Price To Book | 829.81 X | |||
| Price To Sales | 386.72 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Bionomics Stock
If you are still planning to invest in Bionomics ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |